09.10.2024
Hallo Thorsten St.,
"Spannend auch, dass du natürlich sofort bereit bist, eine derartige vermeintliche Information von Pfizer unreflektiert zu glauben, abe nicht, wenn sie sagen, die Impfung wäre effektic und weitestgehend sicher."
Der Artikel des DailySceptic vom 08.10.2024 enthält einen link auf das Dokument " Pfizer’s report C4591021 ‘Interim Report 5’ dated March 12th 2024. It is a Post Authorisation Safety Study (PASS) of Pfizer’s Covid vaccine. "
https://dailysceptic.org/2024/10/08/the-hidden-pfizer-report-that-shows-up-to-40-more-heart-conditions-in-the-vaccinated/
In Pfizer’s report C4591021 ‘Interim Report 5’ kannst Du Dich über die Authenzität und den Wert der angesprochenen Zahlen informieren. Dort heisst es beispielsweise:
"...The following 11 AESIs were discussed further in interim report 5 either at the request of EMA or because they were newly included for analysis as AESIs.
For acute cardiovascular injury the adjusted HRs were 1.38 (95% CI: 0.73, 2.61) in Pedianet, 1.01 (95% CI: 0.99, 1.04) in NHR, 1.38 (95% CI: 1.31, 1.45) in PHARMO, 1.10 (95% CI: 1.03, 1.18) in EpiChron, 0.99 (95% CI: 0.96, 1.03) in SIDIAP, and 1.23 (95% CI: 1.18, 1.27) in CPRD Aurum.
For arrhythmia the adjusted HRs were 1.75 (95% CI: 0.88, 3.49) in Pedianet, 1.03 (95% CI: 1, 1.05) in NHR, 1.36 (95% CI: 1.29, 1.44) in PHARMO, 1.12 (95% CI: 1.04, 1.21) in EpiChron, 0.99 (95% CI: 0.96, 1.03) in SIDIAP, and 1.27 (95% CI: 1.21, 1.33) in CPRD Aurum.
For heart failure, the adjusted HRs were 0.77 (95% CI: 0.73, 0.82) in NHR, 1.29 (95% CI: 1.13, 1.47) in PHARMO, 0.90 (95% CI: 0.80, 1.01) in EpiChron, 0.89 (95% CI: 0.82, 0.96) in SIDIAP, and 1.02 (95% CI: 0.95, 1.09) in CPRD Aurum.
For stress cardiomyopathy, the adjusted HRs were 0.69 (95% CI: 0.18, 2.67) in NHR, 1.49 (95% CI: 0.33, 6.69) in PHARMO, 0.85 (95% CI: 0.21, 3.47) in EpiChron, 1.51 (95% CI: 0.75, 3.04) in SIDIAP, 1.30 (95% CI: 0.53, 3.20) in CPRD Aurum.
For coronary artery disease, the adjusted HRs were 0.99 (95% CI: 0.94, 1.04) in NHR, 1.49 (95% CI: 1.31, 1.69) in PHARMO, 0.97 (95% CI: 0.80, 1.17) in EpiChron, 1.00 (95% CI: 0.91, 1.10) in SIDIAP, 1.40 (95% CI: 1.30, 1.50) in CPRD Aurum.
For myocarditis within 21 days, the adjusted HRs were 0.94 (95% CI: 0.46, 1.94) in NHR, 1.23 (95% CI: 0.13, 11.84) in PHARMO, 3.64 (95% CI: 0.41, 32.53) in EpiChron, 1.05 (95% CI: 0.35, 3.16) in SIDIAP, and 2.30 (95% CI: 0.94, 5.66) in CPRD Aurum.
For cerebral venous sinus thrombosis (CVST), the adjusted HRs were 10.63 (95% CI: 0.23, 1.74) in NHR, 0.90 (95% CI: 0.06, 14.09) in EpiChron, 0.68 (95% CI: 0.11, 4.20) in SIDIAP, 0.43 (95% CI: 0.14, 1.27) in CPRD Aurum.
For secondary amenorrhoea, the adjusted HRs were 0.91 (95% CI: 0.69, 1.21) in NHR, 1.71 (95% CI: 1.34, 2.18) in EpiChron, 0.99 (95% CI: 0.91, 1.07) in SIDIAP, and 1.24 (95% CI: 1.17, 1.30) in CPRD Aurum.
For hypermenorrhoea, the adjusted HRs were 0.62 (95% CI: 0.08, 4.66) in Pedianet, 1.40 (95% CI: 1.23, 1.60) in EpiChron, and 1.02 (95% CI: 0.95, 1.09) in SIDIAP.
For Bell’s Palsy, the adjusted HRs were 1.15 (95% CI: 0.88, 1.50) in NHR, 0.65 (95% CI: 0.28, 1.51) in PHARMO, 0.84 95% CI: (95% CI: 0.34, 2.09) in EpiChron, 0.96 (95% CI: 0.75, 1.24) in SIDIAP, and 0.99 (95% CI: 0.75, 1.29) in CPRD Aurum.
Glomerulonephritis was analysed for the first time in this fifth interim report. No events were identified in Pedianet, NHR or PHARMO. The adjusted HRs were 0.59 (0.22, 1.55) in EpiChron, 1.29 (0.88, 1.87) in SIDIAP and 0.88 (0.67, 1.16) in CPRD Aurum.
LG, Albrecht ( 09.10.2024 )